29Nov
28Nov
Hoping to see again, local woman seeks funds for $15,000 device
Three months ago, Donna Witcher, who is legally blind, walked outside her Torresdale home and identified a stop sign. "It was amazing," said Witcher, a buoyant 52-year-old. "I could actually see." The secret to her sudden vision? A high-tech headset called eSight, which employs a tiny camera that sends high-resolution video through a computer and back to small LED screens in front of the viewer's eyes. Read more >>
26Nov
The Carbonite Inc. (CARB) Upgrade by Oppenheimer Holdings Inc. to “Outperform”
Carbonite Inc. (NASDAQ:CARB) was upgraded by investment analysts at Oppenheimer Holdings Inc. from a “market perform” rating to an “outperform” rating in a research note issued on Tuesday. Read more >>
25Nov
Skyline Receives Canada Approval For STREAMWAY System
Going back to the biotech angle, Skyline Medical Inc. (NASDAQ: SKLN) announced that it received approval for its STREAMWAY System and related disposables from Canadian authorities. The company said that a number of distributors had expressed interest in selling STREAMWAY into Canada’s health-care system. Read more >>
24Nov
Carbonite Inc. (CARB) Breaks into New 52-Week High on November 23 Session
Shares of Carbonite Inc. (CARB) broke into a new 52-week high yesterday, hitting a peak of $19.63. Shares closed at $19.55 after opening at $19.45 for a move of 0.77%. The company now has a market cap of $532.9 million. Read more >>
24Nov
Community raises $15K to help legally blind Independence boy see
Thanks to the community, a young boy is going to be able to see better than ever. Corbin Wolfe’s family raised the $15,000 they needed for his eSight eyewear. They’ve ordered it, and it’s on its way. All of Kansas City fell in love with 7-year-old after they saw a video of him trying on eSight for the very first time. It’s new technology using a camera and monitor to help people who are legally blind see. Read more...
23Nov
Two Biotech Stocks Are Just So Hot Right Now (Corbus Pharmaceuticals Holdings, Inc.)
On November 14, 2016 Corbus Pharmaceuticals Holdings, Inc. (CRBP) announced positive topline results from its Phase 2 study evaluating Resunab (“JBT-101”) for the treatment of diffuse cutaneous systemic sclerosis (“systemic sclerosis”). JBT-101 out-performed placebo in the American College of Rheumatology (ACR) Combined Response Index in diffuse cutaneous Systemic Sclerosis (CRISS) score, reaching 33% at week 16, versus 0% for placebo. Read more >>
23Nov
Skyline Medical (SKLN) Reports Approval in Canada to Market STREAMWAY System
Skyline Medical Inc. (NASDAQ: SKLN) announces that it has received a Medical Device Establishment License to sell the STREAMWAY System and related disposables in Canada. Read more >>
23Nov
Myomo Wants to Help Brain Injury Survivors Overcome Paralysis
For those who experience a stroke or traumatic brain injury, some are left with having to cope and adapt to having a paralyzed or weak limb. According to Cleveland Clinic, patients who have a left-brain stroke may experience paralysis on the right side of their body. Also, as stated by the National Stroke Association, as many as 9 out of 10 stroke survivors have some degree of paralysis immediately following a stroke. Myomo, a medtech company, is working to empower...
22Nov